This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $10,824,505.00 to the University of Wisconsin System to conduct research on cell-matrix interactions promoting idiopathic pulmonary fibrosis. The 4-year project, beginning June 1, 2024, will explore innovative approaches to studying the effects of aberrant collagen morphology on myofibroblast and macrophage activation in idiopathic pulmonary fibrosis. As part of the effort, the Morgridge Institute for Research will be responsible for fluorescence lifetime imaging microscopy (FLIM) experiments, including experimental design, quantitative image analysis, and interpretation of FLIM images. The ultimate goal of this multidisciplinary research is to transform health care for military service members and the public through innovative, impactful medical solutions.
Generated 3/4/25, 7:23 AM